Royal Wolverhampton NHS Trust Wolverhampton Shared Care Agreement Wolverhampton Clinical Commissioning GroupOctober 8th, 2018
FiledOctober 8th, 2018Patient Consent I confirm the risks and benefits of treatment, the baseline tests conducted, the need for monitoring, how monitoring will be arranged, and the roles of the consultant and GP, and my role in shared care have been explained to me. I confirm I have been provided with a copy of this shared care information. I will tell the specialist or GP if I do not have a clear understanding of the treatment. I will share any concerns in relation to the above treatment. I will report any adverse effects to the specialist or GP whilst taking the above treatment. Report immediately if I develop a sore throat, fever, malaise, pallor, purpura (bruising), jaundice which may indicate marrow suppression, blood disorders or liver toxicity. I will inform specialist or GP of any other medication being taken, including over-the-counter products. I will ensure adequate fluid intake during treatment with sulfasalazine. Additionally if prescribing is unlicensed I am aware that sulfasalazine is not